BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27769067)

  • 1. CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasis.
    Tu Z; Chen Q; Zhang JT; Jiang X; Xia Y; Chan HC
    Oncotarget; 2016 Nov; 7(47):76955-76965. PubMed ID: 27769067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
    Jiang C; Zhou L; Wang H; Zhang Q; Xu Y
    Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
    BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
    Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
    BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
    Cao Q; Zhang J; Zhang T
    Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
    Yang Y; Li Q; Guo L
    Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
    Deng YF; Zhou DN; Pan ZY; Yin P
    Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
    Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
    Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
    Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L
    PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
    Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
    Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.
    Qin H; Wang R; Wei G; Wang H; Pan G; Hu R; Wei Y; Tang R; Wang J
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):525-534. PubMed ID: 29214433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of miR-1181 indicates a dismal prognosis for nasopharyngeal carcinoma and promoted cell proliferation and metastasis by modulating Wnt/β-catenin signaling.
    Hua X; Fan KC
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1077-1086. PubMed ID: 30779075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma.
    Zhou LL; Ni J; Feng WT; Yao R; Yue S; Zhu YN; Tang HY; Lv LY; Feng JF; Zhu WG
    Exp Cell Res; 2017 Dec; 361(1):126-134. PubMed ID: 29024700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
    Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
    Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma.
    Ren XY; Wen X; Li YQ; Zhang J; He QM; Yang XJ; Tang XR; Wang YQ; Zhang PP; Chen XZ; Cheng B; Ma J; Liu N
    J Exp Clin Cancer Res; 2018 Sep; 37(1):227. PubMed ID: 30217224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma.
    Xu Y; Zheng Z; Gao Y; Duan S; Chen C; Rong J; Wang K; Yun M; Weng H; Ye S; Zhang J
    Sci Rep; 2017 Apr; 7(1):745. PubMed ID: 28389646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of lncRNA SNHG12 predicts a poor prognosis of nasopharyngeal carcinoma and regulates cell proliferation and metastasis by modulating Notch signal pathway.
    Liu ZB; Tang C; Jin X; Liu SH; Pi W
    Cancer Biomark; 2018; 23(4):603-613. PubMed ID: 30452404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
    Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
    PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.